Positive topline data for CAN-2409 viral immunotherapy achieved primary endpoint by demonstrating statistically significant and clinically meaningful benefit when combined with radiation therapy for ...
Please provide your email address to receive an email when new articles are posted on . Allegro received agreement from the FDA under a special protocol assessment for the design of a phase 2b/3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback